Brief: Oramed Pharmaceuticals Announces The Buy-Back Of Its Common Stock
26/06/2024 14:49
June 26 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED PHARMACEUTICALS INC. ANNOUNCES THE BUY-BACK OF ITS
COMMON
STOCK
* ORAMED PHARMACEUTICALS - AUTHORIZED COMMON STOCK
REPURCHASE PLAN
ALLOWING FOR BUY-BACK OF UP TO $20 MILLION IN MAXIMUM VALUE OF
ITS COMMON STOCK
Source text for Eikon: ID:nPn38j3Dna
Further company coverage: ORMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results